Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00961376
Recruitment Status : Terminated (PI Discretion)
First Posted : August 19, 2009
Last Update Posted : September 29, 2015
Information provided by (Responsible Party):
Providence Health & Services

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : January 2015
  Estimated Study Completion Date : December 2016